William J. Sandborn

Research interests

Publications

• Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00581-5

• STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

  Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2020.12.031

• Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1900750

• Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1606910

• Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1602773

• Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

  The American Journal of Gastroenterology · 2015 · 10.1038/ajg.2015.233

• Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

  New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215739

• Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

  New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215734

• Ulcerative colitis

  The Lancet · 2012 · 10.1016/s0140-6736(12)60150-0

• Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1203572

• Crohn's disease

  The Lancet · 2012 · 10.1016/s0140-6736(12)60026-9

• Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

  Gastroenterology · 2011 · 10.1053/j.gastro.2011.10.032

• Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0904492

• The Natural History of Adult Crohn's Disease in Population-Based Cohorts

  The American Journal of Gastroenterology · 2009 · 10.1038/ajg.2009.579

• Management of Crohn's Disease in Adults

  The American Journal of Gastroenterology · 2009 · 10.1038/ajg.2008.168

• Maintenance Therapy with Certolizumab Pegol for Crohn's Disease

  New England Journal of Medicine · 2007 · 10.1056/nejmoa062897

• Inflammatory bowel disease: clinical aspects and established and evolving therapies

  The Lancet · 2007 · 10.1016/s0140-6736(07)60751-x

• Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

  Gut · 2007 · 10.1136/gut.2006.106781

• Certolizumab Pegol for the Treatment of Crohn's Disease

  New England Journal of Medicine · 2007 · 10.1056/nejmoa067594

• A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis

  Gastroenterology · 2006 · 10.1053/j.gastro.2006.12.038

• Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

  Gastroenterology · 2006 · 10.1053/j.gastro.2006.11.041

• Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

  Gastroenterology · 2006 · 10.1053/j.gastro.2005.11.030

• Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050516

• The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota

  Gastroenterology · 2002 · 10.1053/gast.2002.32362

• The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

  Gastroenterology · 2001 · 10.1053/gast.2001.26279

• A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

  Inflammatory Bowel Diseases · 2000 · 10.1097/00054725-200002000-00002

Current projects

No projects listed.